A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas

RECRUITING

Erasmus Medical Center Rotterdam, Rotterdam

RECRUITING

NYU Langone Health Perlmutter Cancer Center, New York

RECRUITING

Icahn School of Medicine at Mount Sinai, New York

RECRUITING

University Hospital and Research Institute, Madrid

RECRUITING

CHU de Bordeaux, Talence

RECRUITING

Norton Cancer Institute, Louisville

RECRUITING

Hopital Saint Louis, Paris

RECRUITING

UT Southwestern, Dallas

RECRUITING

University of California Los Angeles (UCLA) Medical Center, Santa Monica

RECRUITING

City of Hope, Duarte

RECRUITING

Gustave Roussy, Villejuif

RECRUITING

Massachusetts General Hospital, Boston

RECRUITING

Harvard Medical School - Beth Israel Deaconess Medical Center, Boston

RECRUITING

Rutgers Cancer Institute of New Jersey, New Brunswick

RECRUITING

Amsterdam University Medical Centre, location AMC, Amsterdam

RECRUITING

Hospital Vall d'Hebron, Barcelona

RECRUITING

Royal Cornwall Hospital NHS Trust, Truro

RECRUITING

Southampton General Hospital, Southampton

RECRUITING

The Christie NHS Foundation Trust, Manchester

RECRUITING

Western General Hospital, Edinburgh